Paper Details
- Home
- Paper Details
Pharmacological treatment of alcohol use disorder in patients with psychotic disorders: A systematic review.
Author: AnhøjSimon, HøjlundMikkel, MellentinAngelina Isabella, NielsenAnette Søgaard, NielsenDorthe Grüner, RosenstandNiels Jørgen, SkøtLotte
Original Abstract of the Article :
Patients with psychotic disorders (PD) often have comorbid alcohol use dis- order (AUD), which is typically treated pharmacologically. Up till now, no systematic review has ex- amined the effectiveness and safety of AUD treatment in PD patients. </P> <P> Objectives: This study aimed to systematicall...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.2174/1570159X21666221229160300
データ提供:米国国立医学図書館(NLM)
Pharmacological Treatment of Alcohol Use Disorder in Patients with Psychotic Disorders
The study aims to provide an overview of the effectiveness of pharmacotherapy for alcohol use disorder (AUD) in individuals with comorbid psychotic disorders (PD). The researchers are interested in learning about the efficacy and safety of various medications commonly used to treat AUD and how these drugs may impact drinking outcomes and potential side effects.
Potential Benefits and Risks of Pharmacotherapy for AUD in PD Patients
The researchers found limited evidence supporting the effectiveness of specific pharmacological treatments for AUD in patients with PD. The findings suggest that naltrexone and disulfiram might be helpful in reducing alcohol intake, although further research is needed to confirm these results. They also emphasized the importance of monitoring patients closely for potential side effects and considering the potential risks associated with polypharmacy.
Navigating the Complexities of Comorbid AUD and PD
This study sheds light on the complexities of treating AUD in patients with PD. It's like navigating a desert with multiple pathways – each patient presents a unique set of challenges, and finding the right treatment approach requires careful consideration of their individual needs and the potential benefits and risks of different medications.
Dr. Camel's Conclusion
This study is like a desert oasis, offering a much-needed respite for those struggling with comorbid AUD and PD. It reveals the importance of careful consideration and individualized approaches to treatment, ensuring that patients receive the best possible care and support.
Date :
- Date Completed n.d.
- Date Revised 2022-12-30
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.